UNSPSC 51152049: Alcuronium chloride

This classification denotes a nicotinic antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 490DW6501Y. European Medicines Agency schedules Alcuronium chloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05302MIG. Alcuronium chloride generally arises in the molecular formula C44H50N4O2.2CL.

The term ALCURONIUM CHLORIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 21 no. 12 1967, list 7.) Most nations, for tariff and trade purposes, schedule alcuronium chloride under HS 29399900 and SITC 54149. As of Q4 2014, ALCURONIUM CHLORIDE remains US FDA's Preferred Term for this commodity. Alcuronium chloride bears US NLM identifiers UMLS ID C0205658 and NCI Concept Code C79728.

UNSPSC 51152049 Alcuronium chloride is a Commodity code that shows a significant mismatch between its nominal scope and the work actually being solicited under it in recent state and local opportunities. The recent opportunities tagged to this code involve procurement of naloxone (a medication used to reverse opioid overdose) and safe drug deactivation systems, as well as exploratory market research on direct-to-manufacturer prescription programs — neither of which relates to alcuronium chloride, a neuromuscular blocking agent used in anesthesia. The code exhibits little relevant recent activity aligned with its stated product definition.

Seminole County, Florida posted an IFB (IFB60459723LAS) in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries, with a response deadline of July 26, 2023. The Texas Health and Human Services Commission issued a Request for Information (HHS0017013) in April 2026 to gather vendor capabilities on implementing a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, with a response deadline of April 3, 2026. These opportunities indicate that state and local procurement offices are using this code to tag pharmaceutical and pharmacy-related procurements broadly, rather than specifically for alcuronium chloride. Vendors pursuing this code should verify actual commodity requirements during pre-bid conversations and RFQ cycles, as the code's current tagging does not reflect its nominal scope.